Non-invasive evaluation for patients with portal hypertension receiving TIPS

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program evaluates non-invasive prognostic parameters in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) due to complications from portal hypertension. Patients will be monitored through a structured follow-up program at the University Hospital Bonn, where clinical and laboratory data will be collected and analyzed for their prognostic value. The study aims to enhance understanding of patient outcomes following TIPS procedures using advanced imaging techniques such as echocardiography, CT scans, and MRIs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Insertion of TIPS according to guidelines

Exclusion Criteria:

* Contraindication for TIPS

Where it's running

• University Hospital Bonn
  Bonn, Germany Recruiting

Study contacts

• Principal investigator: Michael Praktiknjo, MD — University of Bonn
• Study coordinator: Michael Praktiknjo, MD
• Email: michael.praktiknjo@ukbonn.de
• Phone: +49(0)228-287 15770

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endohepatology-based reclassification of treatment indication in high-risk MASLD

  This study tests whether an endohepatology assessment can change treatment decisions for adults with high-risk MASLD.

  Recruiting University Hospital Muenster · Münster · NCT07877272

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Austrian PBC Registry

  This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.

  Recruiting Medical University of Vienna · Klagenfurt, Carinthia and 10 other locations · NCT07598669

• 4D-Flow MRI to see portal hypertension and TIPS outcomes in cirrhosis

  This study tests a noninvasive 4D-Flow MRI method to see if it can safely and reliably reflect portal hypertension and predict outcomes for people with cirrhosis, including those needing a TIPS procedure.

  Recruiting at 2 sites Assistance Publique - Hôpitaux de Paris · Paris and 1 other locations · NCT07554183

• Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis

  This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.

  Recruiting Phase 4 Asian Institute Of Medical Sciences · Hyderābād, Sindh · NCT07521332

• Blood clotting and portal vein changes during TIPS placement in cirrhosis

  This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.

  Recruiting Assistance Publique - Hôpitaux de Paris · Villejuif · NCT07439939

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.